Numerous sessions spanned the field of infectious diseases at the IDWeek 2024 meeting. This expert commentary focuses on respiratory syncytial virus (RSV) vaccination, mpox and HIV pre-exposure prophylaxis (PrEP).
Taylor Morrisette, Pharm.D., M.P.H.
Advertisement
Medical University of Carolina School of Pharmacy
Articles by Taylor Morrisette, Pharm.D., M.P.H.
Advertisement
Latest Updated Articles
Expert commentary: A focus on RSV vaccination, mpox and HIV PrEPPublished: December 6th 2024 | Updated:
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
In America, Aging With HIV is a Continuous Challenge
2
What Health Plans Should Ask For in Their PBM Contracts If They Want Transparency | AMCP Nexus 2025
3
Automated Prior Authorization Speeds Approval of GLP-1 Therapies | AMCP Nexus 2025
4
Vaccines in Cancer Care: Evidence, Guidelines & Clinical Considerations
5
